Alejandro González Veliz: The Future of Cardiogenic Shock Lies in Precision Medicine
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn about a recent article by Shashank Shekhar et al., published in Journal of Cardiothoracic and Vascular Anesthesia, adding:
“Cardiogenic shock remains one of the greatest challenges in cardiovascular medicine, with mortality still reaching 30–60% despite advances in reperfusion and mechanical circulatory support.
This updated review highlights a major shift in our approach: moving beyond simply treating hypotension toward recognizing shock early, using structured SCAI staging, invasive hemodynamic assessment, and multidisciplinary shock teams to personalize therapy.
Mechanical circulatory support is not a universal solution – timing, patient selection, and continuous reassessment are what truly determine outcomes.
As our understanding of shock physiology evolves, the future lies in precision medicine: identifying the right patient, selecting the right device, and intervening before irreversible organ injury occurs.
Which aspect of cardiogenic shock management do you think will have the greatest impact over the next decade: earlier diagnosis, invasive hemodynamic monitoring, or newer mechanical circulatory support strategies?”
Title: Cardiogenic Shock: Current Evidence, Guideline Perspectives, and Outcomes
Authors: Shashank Shekhar, Ankit Agrawal, Hussein Almadhoun, Patrick M. Wieruszewski, Gauranga Mahalwar, Tikal Kansara, James A. Nelson, Steven T. Morozowich, Ivan Nunez Gil, Seshasayee Narasimhan, Harish Ramakrishna, Omar Elmadhoun
Other posts featuring Alejandro González Veliz on Hemostasis Today.
-
Aug 9, 2026, 09:49Rana Al-Dhalaan: New Study Examines Viral Infections in Blood Donors
-
Aug 9, 2026, 09:29Michael Wilkinson: How Lp(a) Shapes Coronary Plaque and Cardiovascular Risk
-
Aug 9, 2026, 09:16Preparing for Gene Therapy Starts with Understanding Immunity – WFH
-
Aug 9, 2026, 08:46Christina Pohlman: Uncovering the Autoantibodies Behind APS
-
Aug 9, 2026, 08:29Heba Youssef: Off-Label Doesn’t Mean Off-Guidelines
-
Aug 9, 2026, 08:18Fawaz AlOtaibi: Why Experts Are Challenging the New Stroke Guideline
-
Aug 9, 2026, 08:08Jason Carney: Addressing the National Blood Shortage Through AI-Driven Patient Blood Management
-
Aug 9, 2026, 07:54Hamdy Alkady: FDA Approves the First Oral PCSK9 Inhibitor
-
Aug 9, 2026, 07:51Mostafa Hammam: Antibody Panels in Blood Bank Feeling Like a Chaotic Puzzle? Here is How to Master the Grid